The supraglottic airway I-gel in comparison with ProSeal laryngeal mask airway and classic laryngeal mask airway in anaesthetized patients

European Journal of Anaesthesiology
Won-Jung ShinTomoki Nishiyama

Abstract

The I-gel is a new single-use supraglottic airway device without an inflatable cuff. This study was designed to investigate the usefulness of the I-gel compared with the classic laryngeal mask airway (cLMA) and ProSeal laryngeal mask airway (pLMA) in anaesthetized, paralysed patients. The American Society of Anesthesiologists physical status I-II patients (n = 167) scheduled for orthopaedic surgery were included in this prospective study. General anaesthesia was achieved with intravenous infusion of propofol, remifentanil and rocuronium. The patients were randomly assigned to I-gel, pLMA and cLMA groups (64, 53 and 50 patients, respectively). Properly sized I-gel (No. 3-4) or LMA (No. 4-5) was inserted. We assessed haemodynamic data, airway leak pressure, leak volume, success rates and postoperative complications. There were no differences in the demographic data and haemodynamic data immediately after insertion of devices among the three groups. The airway leak pressures of the I-gel group (27.1 +/- 6.4 cmH2O) and pLMA group (29.8 +/- 5.7 cmH2O) were significantly higher than that of the cLMA group (24.7 +/- 6.2 cmH2O). The success rates for first attempt of insertion were similar among the three groups (P = 0.670). There were...Continue Reading

References

Sep 27, 2002·Anesthesiology Clinics of North America·Charles B Watson
Jun 29, 2005·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Tim M CookMichael Clarke
Aug 17, 2005·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Tim M CookJerry P Nolan
Mar 27, 2007·Anaesthesia·S SharmaM Popat
Jun 7, 2008·European Journal of Anaesthesiology·O A BamgbadeW M Khalaf
Jun 28, 2008·Anaesthesia·G LiewS Ahmed
Aug 14, 2008·Anaesthesia·N A JoshiT M Cook
Jan 20, 2009·British Journal of Anaesthesia·V UppalJ Kinsella

❮ Previous
Next ❯

Citations

Nov 1, 2012·North American Journal of Medical Sciences·Subhro MitraShahin N Jamil
May 26, 2012·The American Journal of Emergency Medicine·Tomoki NishiyamaHong Seuk Yang
Jul 22, 2014·Paediatric Anaesthesia·Souvik MaitraPuneet Khanna
May 10, 2016·Anaesthesia·K El-BoghdadlyM D Wiles
Nov 12, 2015·British Journal of Anaesthesia·C FrerkUNKNOWN Difficult Airway Society intubation guidelines working group
Dec 2, 2015·Journal of Minimal Access Surgery·Jigisha Prahladrai BadhekaAjay Maganlal Rajyaguru
Sep 14, 2013·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Daniel G Ostermayer, Marianne Gausche-Hill
Sep 4, 2015·Journal of Anaesthesiology, Clinical Pharmacology·Nerurkar Aparna AshayTendolkar Bharati Anil
May 18, 2016·Journal of Clinical Anesthesia·Julian Arevalo-LudeñaLuis E Muñoz Alameda
Mar 25, 2015·TheScientificWorldJournal·Sanli MukadderDurmus Mahmut
Jan 28, 2015·International Journal of Critical Illness and Injury Science·Seyed Mohammad Reza HashemianBadiozzaman Radpay
Jul 21, 2017·The Cochrane Database of Systematic Reviews·Muhammad Qamarul HodaHameed Ullah
Jun 5, 2010·European Journal of Anaesthesiology·Bruno Marciniak
Apr 2, 2011·European Journal of Anaesthesiology·Salah A IsmailHayam A Atawia
Dec 20, 2011·Anesthesia and Analgesia·Michael R HernandezAdranik Ovassapian
Apr 16, 2021·Anaesthesia and Intensive Care·Charlotte L TaylorYasmin Endlich
Jun 5, 2021·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Elaheh AllahyariShahram Bamdad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.